Trial of COVID-19 Outpatient Treatment in Individuals With Risk Factors for Aggravation
Conditions
- Corona Virus Infection
- Sars-CoV2
Interventions
- DIETARY_SUPPLEMENT: Vitamins
- DRUG: Telmisartan
- DRUG: Ciclesonide
- DRUG: interferon β-1b
Sponsor
University Hospital, Bordeaux
Collaborators